L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
x38pB5rzNTDWLFVD